0000914190-16-000690.txt : 20160706 0000914190-16-000690.hdr.sgml : 20160706 20160706171113 ACCESSION NUMBER: 0000914190-16-000690 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160701 FILED AS OF DATE: 20160706 DATE AS OF CHANGE: 20160706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eansor Norman David CENTRAL INDEX KEY: 0001270905 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 161754587 MAIL ADDRESS: STREET 1: 8100 SOUTHPARK WAY, A-8 CITY: LITTLETON STATE: CO ZIP: 80120 FORMER NAME: FORMER CONFORMED NAME: EANSOR N DAVID DATE OF NAME CHANGE: 20031120 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-07-01 0000842023 BIO-TECHNE Corp TECH 0001270905 Eansor Norman David 8100 SOUTHPARK WAY, A-8 LITTLETON CO 80120 0 1 0 0 SVP - Novus Biologicals Common Stock 2016-07-01 4 F 0 533 112.24 D 3936 D Stock Option (Right to Buy) 94.35 2021-08-12 Common Stock 15000 15000 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 9375 9375 D Restricted Stock Units Common Stock 1500 1500 D The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock unit grant by directing the Company to withhold shares otherwise issuable pursuant to the previously reported grant. Includes 1,666 shares of restricted stock units that vest on 7/1/17. 3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18. Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. /s/ Elizabeth M. Dunshee as Attorney-in-Fact for N. David Eansor pursuant to Power of Attorney previously filed. 2016-07-06